Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

Jun Yin, Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery Degramont, Eric Van Cutsem, Julien Taieb, Steven R. Alberts, Norman Wolmark, Hans Joachim Schmoll, Leonard B. Saltz, Thomas J. George, Richard R.M. Goldberg, Rachel Kerr, Sara Lonardi, Takayuki Yoshino, Greg Yothers, Axel Grothey, Thierry AndreQian Shi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences